Skip to content

Improving Adherence to Cognitive Rehabilitation

Enhancing Adherence to Cognitive Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02481713
Enrollment
114
Registered
2015-06-25
Start date
2015-12-01
Completion date
2020-09-30
Last updated
2021-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Keywords

psychosis, adherence, motivation

Brief summary

Purpose of study is to evaluate impact of brief motivational interviewing vs. feedback on learning styles in improving attendance to cognitive training

Detailed description

This study is evaluating whether motivational enhancement can improve outcomes of cognitive rehabilitation in Veterans with schizophrenia spectrum disorders. Approximately 120 individuals will be randomized to either a 2-session motivational interview (MI, experimental condition) or a 2-session assessment and feedback on learning styles (CI, active control), and will then be asked to participate in 4 months of cognitive rehabilitation. Booster MI or CI sessions will be administered monthly over the course of the cognitive rehabilitation. Primary outcome is number of cognitive rehabilitation sessions attended.

Interventions

BEHAVIORALmotivational interviewing

motivational interviewing

BEHAVIORALlearning style interviews

interview and feedback about learning style

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of psychotic disorder * 18 years old or older

Exclusion criteria

* meeting criteria for substance abuse/dependence in past 30 days * psychiatric hospitalization in past 30 days * change in psychiatric medications in past 30 days * severe auditory/visual impairment * evidence of developmental disability

Design outcomes

Primary

MeasureTime frameDescription
Number of Sessions Attendedend of four month training periodnumber of cognitive training sessions attended

Countries

United States

Participant flow

Participants by arm

ArmCount
MI Condition
motivational interview condition motivational interviewing: motivational interviewing
56
CI Condition
learning style interview condition learning style interviews: interview and feedback about learning style
58
Total114

Baseline characteristics

CharacteristicMI ConditionCI ConditionTotal
Age, Continuous56.52 years
STANDARD_DEVIATION 10.4
53.34 years
STANDARD_DEVIATION 12.74
55.41 years
STANDARD_DEVIATION 11.65
Education12.52 years
STANDARD_DEVIATION 2.42
13.04 years
STANDARD_DEVIATION 2.21
12.79 years
STANDARD_DEVIATION 2.32
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants5 Participants8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants53 Participants106 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Marital status
ever married
31 Participants29 Participants60 Participants
Marital status
never married
25 Participants29 Participants54 Participants
Number of hospitalizations4.0 hospitalizations4.0 hospitalizations4.0 hospitalizations
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
29 Participants29 Participants58 Participants
Race (NIH/OMB)
More than one race
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
24 Participants26 Participants50 Participants
Sex: Female, Male
Female
13 Participants10 Participants23 Participants
Sex: Female, Male
Male
43 Participants48 Participants91 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 560 / 58
other
Total, other adverse events
1 / 561 / 58
serious
Total, serious adverse events
4 / 564 / 58

Outcome results

Primary

Number of Sessions Attended

number of cognitive training sessions attended

Time frame: end of four month training period

ArmMeasureValue (MEAN)Dispersion
MI ConditionNumber of Sessions Attended7.70 sessionsStandard Deviation 10.82
CI ConditionNumber of Sessions Attended4.98 sessionsStandard Deviation 6.63
p-value: 0.24Wilcoxon (Mann-Whitney)
Primary

Number of Sessions Attended

number of sessions attended among patients who attended at least 1 session

Time frame: end of 4 month training period

Population: participants who attended at least 1 cognitive training session

ArmMeasureValue (MEAN)Dispersion
MI ConditionNumber of Sessions Attended10.51 sessionsStandard Deviation 11.43
CI ConditionNumber of Sessions Attended7.23 sessionsStandard Deviation 6.91
p-value: 0.000195% CI: [1.25, 1.69]Regression, zero-inflated Poisson

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026